Non-small cell lung cancer - crizotinib or entrectinib - initial authority application form (PB156)

Use this form to apply for initial PBS subsidised treatment with crizotinib or entrectinib for Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer.